International reference: 1 US FDA recall for this ingredient

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes (detomidine)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Zambia.

Registered Zambia · ZAMRA

Dormosedan Injection 5ml

Detomidine Hydrochloride

327/726V Solution for Injection INN generic

What it does

Detomidine is a medication used primarily in veterinary medicine as a sedative and analgesic to calm animals during procedures.

Commonly used for: sedation in animals, pain relief in animals

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
327/726V
Registration date
2026-06-25
Expiry date
2031-06-24
Status
Registered/Compliant
Active ingredient
Detomidine Hydrochloride
Strength
-
Pack size
-
Therapeutic class
-
RxNorm RxCUI
22672
Manufacturer / MAH
Zoetis
Applicant / LTR
ZOETIS BELGIUM SA
Country of origin
Belgium
Manufacturer location
Mercuriusstraat 20, 1930 Zaventem, Belgium

Source: Zambia Medicines Regulatory Authority · fetched 2026-06-28 06:27:28 · updated 2026-10-19 03:39:58

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Detomidine is a medication used primarily in veterinary medicine as a sedative and analgesic to calm animals during procedures.

What it treats

  • sedation in animals
  • pain relief in animals

How it works

Detomidine works by slowing down the nervous system, which helps to relax animals and relieve pain.

Who it's for

This medication is used for animals that need sedation or pain management during medical procedures.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: detomidine

BNF-referenced

Detomidine is a potent alpha-2 adrenergic agonist primarily used in veterinary medicine as a sedative and analgesic agent. It is effective for sedation in horses and other large animals, providing both tranquillization and pain relief. Detomidine acts on the central nervous system, leading to a decrease in sympathetic outflow and sedation.

Indications

  • Sedation in horses
  • Analgesia in veterinary practices
  • Pre-anesthetic medication

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing information.

Adults: The typical adult dose for sedation is 10-20 micrograms/kg intravenously or intramuscularly, adjusted based on the clinical response.

Mechanism of action

Detomidine selectively binds to alpha-2 adrenergic receptors, specifically subtypes A and B. This binding inhibits the release of norepinephrine, resulting in decreased sympathetic nervous system activity. The sedative effects are mediated through the activation of imidazoline receptors and inhibition of adenylate cyclase activity, leading to reduced neuronal excitability.

Pharmacodynamics

Detomidine produces sedation, analgesia, and muscle relaxation. Its effects are dose-dependent, with higher doses resulting in deeper sedation and longer duration of action. The drug's analgesic properties are beneficial during surgical procedures or in cases of colic in horses.

Pharmacokinetics

Detomidine is rapidly absorbed when administered intravenously or intramuscularly. The onset of sedation typically occurs within minutes, with peak effects seen around 30 minutes post-administration. The drug is metabolized in the liver, primarily by conjugation to inactive metabolites, and excreted via urine. The elimination half-life varies, generally within 1 to 2 hours.

Contra-indications

  • Hypersensitivity to detomidine or any of its components
  • Severe cardiovascular disease
  • Severe respiratory disease
  • Pregnant or lactating animals

Adverse effects

  • Sedation
  • Ataxia
  • Bradycardia
  • Hypotension
  • Respiratory depression
  • Gastrointestinal effects such as vomiting

Interactions

  • Other sedatives and anesthetics may enhance the effects of detomidine
  • Opioids may have additive effects when used with detomidine
  • Alpha-2 adrenergic agonists may interact with detomidine

Precautions

  • Use with caution in geriatric or debilitated patients
  • Monitor cardiovascular and respiratory function closely
  • Adjust dosage for individual animals based on their response

Pregnancy

Detomidine is contraindicated in pregnant animals as it can cause adverse effects on the fetus.

Breast-feeding

The safety of detomidine in lactating animals has not been established, use with caution.

Storage

Store at room temperature, protect from light, and keep out of reach of children.

Formulations

  • Injectable solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: detomidine

PubChem CID 56032

Molecular formula: C12H14N2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.